BBNX
Beta Bionics, Inc. Common Stock
BBNX
BBNX
115 hedge funds and large institutions have $659M invested in Beta Bionics, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 29 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+12
Holders Change %
+11.65%
% of All Funds
1.54%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
27
Increased
36
Reduced
29
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$22.5M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$13.8M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$12.7M |
| 4 |
VPC
Vestal Point Capital
New York
|
+$8.01M |
| 5 |
Millennium Management
New York
|
+$7.89M |
Top Sellers
| 1 |
PVI
Pura Vida Investments
New York
|
-$1.07B |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$13.2M |
| 3 |
BlackRock
New York
|
-$8.28M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.92M |
| 5 |
Holocene Advisors
New York
|
-$4.91M |
